Gara Jalqabaatti › Dhibee Harkaa (Hepatocellular Carcinoma) › New York

Qorannoo klinikaalii Dhibee Harkaa (Hepatocellular Carcinoma) New York keessatti

Qorannoo 33 Dhibee Harkaa (Hepatocellular Carcinoma) f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of ZW251 in Participants With Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07164313

A Phase 1 Study of the Safety and Tolerability of CTX-10726

START New York, Lake Success

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07419841

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #60, New York
Exelixis Clinical Site #6, New York
Exelixis Clinical Site #76, Syracuse

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05176483

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Research Facility, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06726161

National Liver Cancer Screening Trial

The Feinstein Institutes, Northwell Health, Inc., Manhasset

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06084234

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Local Institution - 0100, Mineola

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07291076

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Columbia University Irving Medical Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06915753

A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center Mskcc, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT06427941

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

NYU Langone Health, New York
Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York
fi 2 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin 22 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06486454

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Montefiore Einstein Comprehensive Cancer Center, The Bronx

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT04864054

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Research Site, New York
Research Site, New York
Research Site, New York

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06921785

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

New York Cancer & Blood Specialists, New York
University of Rochester - Wilmot Cancer Institute, Rochester

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT06582017

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1/2

12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05919264

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Northwell Health/Center for Advanced Medicine, Lake Success
Mount Sinai Hospital, New York
Montefiore Medical Center-Einstein Campus, The Bronx
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07166406

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06242470

HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer

Montefiore Medical Center, The Bronx

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06899152

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NYU Langone Health, New York
Icahn School of Medicine At Mount Sinai Prime, New York
Clinical Research Alliance, Inc, Westbury
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT06330064

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

Roswell Park Cancer Institute, Buffalo

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05168163

Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

Icahn School of Medicine at Mount Sinai, New York

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07059494

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Clinical Trial Site, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06600321

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

VA NY Harbor Healthcare System, New York, NY, New York
James J. Peters VA Medical Center, Bronx, NY, The Bronx

Namoota walitti qabaa jira

Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT05486572

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 16 fi ol · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT07197554

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

USA04-0, New York

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT06953089

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Memorial Sloan Kettering Cancer Center - New York, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT05440708

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Roswell Park Comprehensive Cancer Center, Buffalo
Montefiore Medical CenterMontefiore Medical Park, The Bronx

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT05733598

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

Montefiore Medical Center, The Bronx

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT05366829

HOPE Against Cancer Recurrence in HCC

Rutgers New Jersey Medical School (New York), New York

Namoota walitti qabaa jiraSadarkaa 4

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Mud-2025 · NCT06717919

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Research Site 107, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
fi 2 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

The Dragon PLC Trial (DRAGON-PLC)

Memorial Sloan Kettering Cancer Center, New York

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Cam-2025 · NCT06914648

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Memorial Sloan-Kettering Cancer Center, New York

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Sad-2024 · NCT05824975

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.